Table 3.
Characteristics | Mean Difference | 95.00% CI of Difference | Adjusted P-values | Significance |
---|---|---|---|---|
Gender | ||||
Normal (n=45) vs Male (n=33) | 2.230 | 0.514 to 3.945 | 0.007 | ** |
Normal (n=45) vs Female (n=12) | 1.646 | −0.785 to 4.078 | 0.24 | ns |
Male (n=33) vs Female (n=12) | −0.583 | −3.107 to 1.939 | 0.845 | ns |
Age | ||||
Normal (n=45) vs >60 years (n=30) | 2.06 | 0.292 to 3.827 | 0.018 | * |
Normal (n=45) vs <60 years (n=15) | 2.104 | −0.131 to 4.34 | 0.069 | ns |
>60 years (n=30) vs <60 years (n=15) | 0.044 | −2.326 to 2.416 | 0.998 | ns |
Smoking history | ||||
Normal (n=45) vs Yes (n=30) | 2.137 | 0.370 to 3.904 | 0.013 | * |
Normal (n=45) vs No (n=15) | 1.949 | −0.286 to 4.184 | 0.100 | ns |
Yes (n=30) vs No (n=15) | −0.188 | −2.559 to 2.182 | 0.980 | ns |
Histologic grade | ||||
Normal (n=45) vs Grade 1 (n=9) | −2.089 | −5.213 to 1.034 | 0.303 | ns |
Normal (n=45) vs Grade 2 (n=15) | −2.561 | −5.111 to −0.010 | 0.048 | * |
Normal (n=45) vs Grade 3 (n=21) | −2.811 | −5.072 to −0.550 | 0.008 | ** |
Grade 1 (n=9) vs Grade 2 (n=15) | −0.471 | −4.079 to 3.135 | 0.986 | ns |
Grade 1 (n=9) vs Grade 3 (n=21) | −0.721 | −4.130 to 2.686 | 0.94 | ns |
Grade 2 (n=15) vs Grade 3 (n=21) | −0.250 | −3.142 to 2.642 | 0.995 | ns |
Pathologic stage | ||||
Normal (n=45) vs Stage 2 (n=18) | 2.502 | 0.417 to 4.586 | 0.014 | * |
Normal (n=45) vs Stage 3 (n=27) | 1.789 | −0.030 to 3.609 | 0.054 | ns |
Stage 2 (n=18) vs Stage 3 (n=27) | −0.712 | −2.987 to 1.561 | 0.736 | ns |
Notes: *P<0.05; **P< 0.01.
Abbreviation: ns, non-significant.